Interestingly, while no difference between HBD and COVID-19 patients was observed in CD14+ monocytes stained for HERV-W ENV, a significant expression was also observed in CD19+ B cells from COVID-19 patients, compared to HBD (p < 0.0001) (Figure 3A). This evidence concerns the gene CD14 and COVID-19.